City-based healthcare major, Cadila Healthcare, posted a standalone net profit of Rs 347 crore for the quarter ended March 2015, up 60 per cent against Rs 217 crore in the corresponding period last year, the company said on Friday.

The company's standalone net sales stood at Rs 1,338 crore against Rs 990 crore in the same period last year, showing a growth of 35 per cent.

For the financial year ended March 2015, Cadila Healthcare posted a net profit of Rs 1,271 crore against Rs 904 crore in the previous year. Net sales for the year stood at Rs 4,686 crore, against Rs 3,524 crore in the previous year.

The board of directors in their meeting held on Friday proposed a dividend of 240 per cent or Rs 12 per equity share of Rs 5 each.

On a consolidated basis, the company reported a net profit of Rs 350 crore for the quarter ended March 2015 against Rs 239 crore in the corresponding quarter a year ago, up by 44 per cent. Net sales for the quarter stood at Rs 2,247 crore against Rs 1,916 crore in the corresponding quarter last year.

For fiscal 2014-15, the consolidated net profit stood at Rs 1,151 crore, 43 per cent up from the Rs 804 crore recorded in the previous year. Net sales for the year were at Rs 8,497 crore against Rs 7,060 crore in the previous year.

Cadila Healthcare shares surged on the Bombay Stock Exchange (BSE) to Rs 1700, up over 2 per cent from its previous close.